Olympus Corporation (FRA:OLY1)

Market Cap	11.06B -30.7%
Revenue (ttm)	5.63B +0.4%
Net Income	564.77M +30.3%
EPS	0.50 +35.7%
Shares Out	n/a
PE Ratio	19.58
Forward PE	n/a
Dividend	0.12 (1.21%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	15
Open	9.84
Previous Close	9.97
Day's Range	9.84 - 9.84
52-Week Range	9.53 - 14.93
Beta	n/a
RSI	34.67
Earnings Date	Feb 13, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platfo...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1919
• Employees: 29,297
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OLY1

Financial Performance

In fiscal year 2025, Olympus's revenue was 997.33 billion, an increase of 6.53% compared to the previous year's 936.21 billion. Earnings were 117.86 billion, a decrease of -51.41%.

Financial numbers in JPY